Efficacy of intra-articular Hylan G-F 20 on osteoarthritis of the knee

Pain Clinic

Volumn 15, Issue 4, 2003, Pages 459-466

  Tetik, Sevgi ^a   Öneş, Kadriye ^b   Tetik, Cihangir ^c  

^a MALTEPE UNIVERSITY   (Turkey)

^b Istanbul Phys Med and Rehab Ctr   (Turkey)

^c MARMARA UNIVERSITY   (Turkey)

Author keywords

Intra articular Hylan G F 20; Knee osteoarthritis; Pain; Physical function

Indexed keywords

ANALGESIC AGENT; HYLAN G F 20; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; KNEE FUNCTION; KNEE OSTEOARTHRITIS; KNEE PAIN; MAJOR CLINICAL STUDY; MALE; PHYSIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RIGIDITY; SIDE EFFECT; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 10744227829     PISSN: 01691112     EISSN: None     Source Type: Journal    
DOI: 10.1163/156856903770196863     Document Type: Article

References (34)

1. Goorman SD, Watanabe TK, Miller EH, et al., Functional outcome in knee osteoarthritis after treatment with Hylan G-F 20: A prospective study, Arch Phys Med Rehabil 81, 479-83 (2000).
2. Davis MA, Ettinger WH, Neuhaus JM, et al., Knee osteoarthritis and physical functioning: evidence from NHANES I. Epidemiologic Follow-up study, J Rheumatol 18, 591-8 (1991).
3. Dieppe P, Osteoarthritis, Acta Orthop Scand 281 (Suppl.), 2-5 (1998).
4. Adams ME, An analysis of clinical studies of the use of crosslinked hyaluronan, Hylan, in the treatment of osteoarthritis, J Rheumatol 20 (Suppl. 39), 16-8 (1993).
5. Wolfe NM, Lichtenstein DR, Singh G, Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs, New Engl J Med 340, 1888-98 (1999).
6. Creamer P, Sharif M, George E, Intra-articular hyaluronic acid in osteoarthritis of the knee. An investigation into mechanism of action, Osteoarthritis Cartilage 2, 133-40 (1994).
7. Adams ME, Atkinson MH, Lussier AJ, et al., The role of viscosupplementation with Hylan G-F 20 (synvisc) in the treatment of osteoarhritis of the knee: a Canadian multicenter trial comparing Hylan G-F alone, Hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDS) and NSAIDs alone, Osteoarthritis Cartilage 3, 213-26 (1995).
8. Peyron JG, Intra-articular hyaluronan injections in the treatment of osteoarthritis: state of the art review, J Rheumatol 39 (Suppl.), 10-5 (1993).
9. Lussier A, Gividino AA, McFarlane CA, et al., Viscosupplementation with Hylan for the treatment of osteoarthritis: findings from clinical practice in Canada, J Rheumatol 23, 1579-85 (1996).
10. Altman R, Asch E, Bloch D, Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association, Arthritis Rheum 29, 1039-49 (1986).
11. Lawrence JS, Bremner JM, Bier F, Osteo-arthritis prevalence in population and relationship between symptoms and x-ray changes, Ann Rheum Dis 25, 1-24 (1996).
12. Bellamy N, Buchanan WW, Goldsmith CH, et al., Validation study of WOMAC: a health status instrument for measuring clinically important patient-relevant outcomes following total hip or knee arthroplasty in osteoarthritis, J Rheumatol 15, 1833-40 (1988).
13. Bellamy N, Campbell J, Stevens J, et al., Validation study of a computerized version of the Western Ontario and McMaster Universities VA 3.0 Osteoarthritis Index, J Rheumatol 24, 2413-5 (1997).
14. Creamer P, Hochberg MC, Osteoarthritis, Lancet 350, 503-9 (1997).
15. Mamlin LA, Melfi CA, Parchman ML, Management of osteoarthritis of the knee by primary care physicians, Arch Family Med 7, 563-7 (1998).
16. Bradley JD, Brandt KD, Katz BP, et al., Comparison of an anti-inflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acitaminofen in the treatment of patients with osteoarthritis of the knee, New Engl J Med 325, 87-91 (1991).
17. Block JA, Schnitzer TJ, Therapeutic approaches to osteoarthritis, Hosp Prac 32, 159-63 (1997).
18. van Baar ME, Assendelft WJ, Dekker J, et al., Effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee, Arthritis Rheum 42, 1361-9 (1999).
19. Dekker J, Boot B, van der Woude L, et al., Pain and disability in osteoarthritis: a review of biobehavioral mechanisms, J Behav Med 15, 189-214 (1992).
20. Brandt KD, The importance of nonpharmacologic approaches in management of osteoarthritis, Am J Med 105, 39S-44S (1998).
21. Maheu E, Hyaluronan in knee osteoarthritis: a review of clinical trials with Hyalgan, Eur J Rheumatol Inflamm 15, 17-24 (1995).
22. Scale D, Wobig M, Wolpert W, Viscosupplementation of osteoarthritic knees with Hylan: a treatment schedule study, Curr Ther Res 55, 220-32 (1994).
23. Gotoh S, Miyazaki K, Onaya J, et al., Experimental knee pain model in rats and analgesic effect of sodium hyaluronate (SPH), Nippon Yakurigaku Zasshin 92, 17-27 (1988).
24. Creamer P, Sharif M, George E, Intra-articular hyaluronic acid in osteoathritis of the knee: an investigation into mechanism of action, Osteoarthritis Cartilage 2, 133-40 (1994).
25. Swann DA, Radin EL, Nazimiec M, et al., Role of hyaluronic acid in joint lubrication, Ann Rheum Dis 33, 318-26 (1974).
26. Balasz EA, Denlinger JL, Viscosupplementation: a new concept in the treatment of osteoarthritis, J Rheumatol 39 (Suppl.), 3-9 (1993).
27. Puttick MPE, Wade JP, Chalmers A, Acute local reactions after intra-articular Hylan for osteoarthritis of the knee, J Rheumatol 22, 1311 (1995).
28. Ali Y, Weinstein M, Joki P, Acute pseudogout following intra-articular injection of high molecular weight hyaluronic acid, Am J Med 107, 641-2 (1999).
29. Wigren A, Wik O, Faalk J, Intra-articular injection of high-molecular hyaluronic acid, Acta Orthop Scand 47, 480-5 (1976).
30. Frizziero L, Govoni E, Bachin P, Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study, Clin Exp Rheumatol 16, 441-9 (1998).
31. Lohmander LS, Dalen N, Englund G, et al., Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised double blind, placebo controlled multicenter trial, Ann Rheumatol Dis 55, 424-31 (1996).
32. Wobig M, Dickhut A, Maier R, et al., Viscosupplementation with Hylan G-F 20: a 26 week controlled trial of efficacy and safety in osteoarthritic knee, Clin Ther 20, 410-23 (1998).
33. Corrado EM, Peluso GF, Gigliotti S, et al., The effects of intra-articular administration of hyaluronic acid on osteoarthritis of the knee: A clinical study with immunological and biochemical evaluations, Eur J Rheumatol Inflamm 15 (Issue I) (1995).
34. Petrella RJ, Disilvestro MD, Hildebrand C, Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee. A randomized, double-blind, placebo-controlled clinical trial, Arch Intern Med 162, 292-8 (2002).